Compare BIO-TECHNE Corp (TECH) vs Wynn Resorts, Limited (WYNN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BIO-TECHNE Corp vs Wynn Resorts, Limited — how do they compare? BIO-TECHNE Corp trades at $72.46 (market cap $11.37B), while Wynn Resorts, Limited trades at $75.65 (market cap $7.72B). The key difference: BIO-TECHNE Corp is the larger of the two by market cap, and Wynn Resorts, Limited pays the higher dividend (1.33%). Which is the better fit depends on your goals — on Pluang, investors hold BIO-TECHNE Corp for 63 Days and Wynn Resorts, Limited for 76 Days on average.
| TECH | WYNN | |
|---|---|---|
Market Cap | $11.37B | $7.72B |
Volume | 3,153,511 | 2,401,826 |
Sector | Health | Consumer Cyclical |
52-Week High | $72.61 | $133.09 |
52-Week Low | $43.31 | $74.97 |
Typical Hold Time | 63 Days | 76 Days |
Enterprise Value | $11.40B | $17.96B |
Dividend Yield | 0.44% | 1.33% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
TECH trades at $72.53, near its 52-week high of $72.70, with a bullish technical signal and strong institutional interest. Recent earnings show mixed results, beating in Q2 2026 but missing in Q1. The company maintains solid profitability with a 65.77% gross margin, though net income declined to $73.40M in 2025. Shareholders approved an acquisition by Merck KGaA at $73.00 per share, a key near-term catalyst.
Outlook is positive due to the pending acquisition, but risks include execution challenges and valuation concerns with a high P/E of 62.53. Analyst consensus is divided with 46% buy ratings, suggesting cautious optimism. The stock offers limited upside to the acquisition price, making it suitable for event-driven investors.
Wynn Resorts (WYNN) trades at $75.29, down 1.74% on the day, with a bearish technical signal but oversold RSI readings. The company reported mixed Q2 2026 earnings, beating EPS estimates but facing margin pressure in the U.S. Revenue has grown from $3.8B in 2022 to $7.1B in 2025, though net income margins have compressed. Recent news highlights strong Macau performance and a $900 million senior notes offering to fund expansion.
The outlook is cautiously optimistic, supported by analyst consensus favoring a Buy rating with a $132.36 price target, implying significant upside. However, risks include high debt levels, rising capital expenditures for new projects, and potential volatility in key markets like Macau and Las Vegas. The stock presents a value opportunity if operational improvements and international expansions yield expected returns.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BIO-TECHNE Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Read more on TECH →About Wynn Resorts, Limited
Wynn Resorts operates luxury casinos and resorts. The company was founded in 2002 by Steve Wynn, the former CEO. The company operates four megaresorts: Wynn Macau and Encore in Macao and Wynn Las Vegas and Encore in Las Vegas. Cotai Palace opened in August 2016 in Macao, Encore Boston Harbor in Massachusetts opened June 2019. Additionally, we expect the company to begin construction on a new building next to its existing Macao Palace resort in 2023, which we forecast to open in 2026. The company also operates Wynn Interactive, a digital sports betting and iGaming platform. The company received 76% and 24% of its 2019 prepandemic EBITDA from Macao and Las Vegas, respectively.
Read more on WYNN →
